Stockreport

Healthy Returns: What's next for Novo Nordisk's next-generation obesity drug CagriSema after trial miss [CNBC]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Tom Little | Reuters A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. S [Read more]